Cerebellar
infarction represents approximately 2.3 % of acute strokes overall.29 These can
result from occlusion of the superior cerebellar artery (SCA), anterior
inferior cerebellar artery (AICA), or the posterior inferior cerebellar artery
(PICA). Larger cerebellar infarcts produce symptoms and signs localizing to the
brainstem, such as diplopia, dysarthria, limb ataxia, dysphagia, and weakness
or numbness.
Approximately 10% of patients with cerebellar infarction can present with isolated vertigo, that is, vertigo with no localizing findings on motor, sensory, reflex, cranial nerve, or limb coordination examination. Most of these are infarcts of the medial branch of the PICA (96%).
Approximately 10% of patients with cerebellar infarction can present with isolated vertigo, that is, vertigo with no localizing findings on motor, sensory, reflex, cranial nerve, or limb coordination examination. Most of these are infarcts of the medial branch of the PICA (96%).
Vertigo is defined as a pathologic illusion of movement. Most commonly experienced as a spinning sensation, it arises from a pathologic imbalance in the peripheral or central vestibular system.
Red flags in vertigo :
2. Total ipsilateral hearing loss
3. Inability to walk without support
4. Direction-changing nystagmus
Rosen's provide this diagnostic algorithm.
Enter the HINTS examination
The HINTS examination is proposed as a method to elicit enough information to differentiate peripheral and central causes of constant vertigo (eg vestibular neuronitis vs cerebellar stroke) in a 3-test examination:
- Head Impulse testing
- Nystagmus
- Test of Skew
The HINTS study was published in 2009, describing 101 patients assessed by neurologists after referral for acute vestibular syndrome (vertigo, nystagmus, nausea/vomiting, head-motion intolerance, unsteady gait) in the presence of ≥1 stroke risk factor. These 3 examinations were found to have a sensitivity of 100% and specificity of 96% for a central lesion using diffusion-weighted imaging MRI at up to 48 hours as the gold standard. In fact, this combination of examination findings was more sensitive than MRI at presentation, which was falsely negative in 8 patients with an ischaemic stroke (and detected on MRI up to 3 days later).
Obviously, this study was set in a group of high-risk patients with a high incidence of central causes. The clinical examination was done by neurologists, and there was no blinding of results.
Is there other evidence?
One recent study compared HINTS to traditional evaluation for stroke risk with ABCD2, showing HINTS to be more sensitive for detecting a central cause than both ABCD2 score and early MRI: Newman-Toker et al, HINTS outperforms ABCD2 to screen for stroke in acute continuous vertigo and dizziness. Acad Emerg Med. 2013 Oct;20(10):986-96
This study drew some criticism for using the ABCD2 score, which was derived to predict stroke risk after TIA, and for patient selection (190 patients with acute, persistent vertigo with nystagmus plus nausea/vomiting, head motion intolerance, and new gait unsteadiness—findings that are sufficient to, and for all these patients, did, justify hospitalisation from the ED). The proportion with posterior fossa stroke (59.5%) or other central causes (5.8%) was very high, whereas the proportion of unselected dizziness patients with stroke or TIA is 3.2%.
Opinion
The question
should not be how accurate is the HINTS exam, but rather is it accurate enough
to change decision-making on the undifferentiated AVS patient? The HINTS exam
has the potential to supplement us in two ways.
First in the high
risk patient who you intend to admit for further evaluation, the HINTS exam
would be used to rule out a central cause to their symptoms and the patient
could be safely discharged.
The second, that
HINTS could aid our decision making process is in the low risk patient to help
identify a subtle presentation of central vertigo which would otherwise go
unnoticed. In the Newman-Toker trials, the HINTS exam was performed on a cohort
that exhibited either trunk ataxia or gait instability, both of which are
ominous findings. These are the high risk patients which we hope the HINTS exam
will help us to further risk stratify into those who require admission and
those who can be safely discharged. In a group as high risk as these, a sensitivity
of 96% is not acceptable to safely rule out a central cause of the patient’s
vertigo. Not to mention we have no idea about its inter-rater reliability and
how well these tests function in the novice’s hands.
Conversely how the
HINTS exam performs in a group of AVS patients who are far more benign in their
presentation is unknown. When used in a lower risk cohort (similar to the
typical population we see in the Emergency Department with AVS), it may in fact
lead to more diagnostic testing without a significant increase to our
diagnostic yield.
Clearly the HINTS
exam is an interesting and useful tool to evaluate patients with AVS. Whether
it will ever be refined enough to aid us in our critical reasoning for the
undifferentiated ED patient is still unknown. Presently it has been tested on a
highly selected population, by a single tester, without any examination of
inter-rater reliability. Until we can examine the HINTS performance in the ED,
as performed by ED physicians, on our patients, we do not know what, if any
benefit it contributes to our clinical decision-making.
Visit my treatment of Vertigo >> obatvertigo.net
ReplyDelete